Gujarat Terce Corrects MD & CEO Re-appointment Tenure
Gujarat Terce Laboratories Ltd 路 Change in Management 路 21 Aug 2026, 9:34 pm
Gujarat Terce Corrects MD & CEO Re-appointment Tenure Gujarat Terce Laboratories has corrected the tenure for the re-appointment of Mr. Aalap Prajapati as MD & CEO. An earlier intimation on 29 May'26 mistakenly stated a five-year term. The company now clarifies the correct tenure is three years, effective from 28 Oct'26 to 27 Oct'29. This revision was approved by shareholders at the 41st AGM on 21 Aug'26. Mr. Prajapati has over 15 years of pharmaceutical industry experience and is the son of Whole-Time Director, Mr. Natwarbhai Prajapati.
Original exchange filing (PDF)
More announcements from Gujarat Terce Laboratories Ltd
- Detailed disclosure is attached. 路 05 Nov 2026
- Detailed disclosure is attached. 路 05 Nov 2026
- In compliance with Regulation 30 read with Schedule III, Regulation 33 and other applicable provisions of the SEBI Listing Regulations, the Board of Directors of Gujarat Terce Laboratories .... 路 05 Nov 2026
- Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve The Unaudited Standalone .... 路 05 Nov 2026
- Detailed disclosure is attached 路 21 Aug 2026
- Detailed disclosure is attached. 路 21 Aug 2026
- Detailed disclosure is attached. 路 21 Aug 2026
- Detailed disclosure is attached. 路 07 Aug 2026
